Trial Profile
Prospective study investigating efficacy of oral and subcutaneous iron chelators in children suffering from β-thalassemia
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Deferiprone (Primary) ; Deferoxamine (Primary)
- Indications Thalassaemia
- Focus Therapeutic Use
- 02 Dec 2015 New trial record